Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 2 Interventional Accepts healthy volunteers

Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV

ClinicalTrials.gov ID: NCT02560805

Public ClinicalTrials.gov record NCT02560805. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 7:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Post-Traumatic Stress Disorder and Cardiovascular Disease Risk: Role of Sympathetic Overactivity and Angiotensin II

Study identification

NCT ID
NCT02560805
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Emory University
Other
Enrollment
134 participants

Conditions and interventions

Interventions

  • Atenolol Drug
  • Cold Pressor Test (CPT) Procedure
  • Combat virtual reality video clip Behavioral
  • Handgrip Exercise Procedure
  • Losartan Drug
  • Microneurography Procedure
  • Phenylephrine Drug
  • Sham Transcutaneous Vagal Nerve Stimulation (tVNS) Device
  • Sodium Nitroprusside (SNP) Drug
  • Transcutaneous Vagal Nerve Stimulation (tVNS) Device

Drug · Procedure · Behavioral + 1 more

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2015
Primary completion
Mar 29, 2027
Completion
Mar 29, 2027
Last update posted
May 17, 2026

2015 – 2027

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Atlanta VA Medical Center Decatur Georgia 30033 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02560805, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 17, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02560805 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →